UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Modelling NAFLD disease burden in four Asian regions—2019‐2030

Alimentary pharmacology & therapeutics, 2020-04, Vol.51 (8), p.801-811

2020

Volltextzugriff (PDF)

Treatment of chronic hepatitis C in Asia: When East meets West

Journal of gastroenterology and hepatology, 2009-03, Vol.24 (3), p.336-345

2009

Volltextzugriff (PDF)

Editorial: PNPLA3 genotype and liver diseases—more than non‐alcoholic fatty liver disease

Alimentary pharmacology & therapeutics, 2020-07, Vol.52 (2), p.390-391

2020

Volltextzugriff (PDF)

Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta‐analysis of a complex issue

Liver international, 2018-03, Vol.38 (3), p.503-514

2018

Volltextzugriff (PDF)

Path from the discovery to the elimination of hepatitis C virus: Honoring the winners of the Nobel Prize in Physiology or Medicine 2020

The Kaohsiung journal of medical sciences, 2021-01, Vol.37 (1), p.7-11

2021

Volltextzugriff (PDF)

Letter to the Editor: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter

Hepatology (Baltimore, Md.), 2020-08, Vol.72 (2), p.781-781

2020

Volltextzugriff (PDF)

Impact of interleukin‐1β single nucleotide polymorphisms and depressive symptoms in individuals with chronic viral hepatitis

The Kaohsiung journal of medical sciences, 2024-01, Vol.40 (1), p.94-104

2024

Volltextzugriff (PDF)

Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response

Alimentary pharmacology & therapeutics, 2024-03, Vol.59 (6), p.742-751

2024

Volltextzugriff (PDF)

Role of interleukin‐28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

Hepatology (Baltimore, Md.), 2011-01, Vol.53 (1), p.7-13

2011

Volltextzugriff (PDF)

Long-term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety

The American journal of gastroenterology, 2024-03, Vol.119 (3), p.486-496

2024

Volltextzugriff (PDF)

The interplay of metabolic dysfunction‐associated fatty liver disease and viral hepatitis on liver disease severity: A large community‐based study in a viral endemic area

Journal of gastroenterology and hepatology, 2024-01, Vol.39 (1), p.193-201

2024

Volltextzugriff (PDF)

Exosome‐derived differentiation antagonizing non‐protein coding RNA with risk of hepatitis C virus‐related hepatocellular carcinoma recurrence

Liver international, 2021-05, Vol.41 (5), p.956-968

2021

Volltextzugriff (PDF)

More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma

Liver international, 2018-05, Vol.38 (5), p.895-902

2018

Volltextzugriff (PDF)

The identification and phylogenetic analysis of SARS‐CoV‐2 delta variants in Taiwan

The Kaohsiung journal of medical sciences, 2023-06, Vol.39 (6), p.624-636

2023

Volltextzugriff (PDF)

Prevalence, proportions of elevated liver enzyme levels, and long-term cardiometabolic mortality of patients with metabolic dysfunction-associated steatotic liver disease

Journal of gastroenterology and hepatology, 2024-05, Vol.39 (9), p.1939-1949

2024

Volltextzugriff (PDF)

Severe acute exacerbation of HCV infection in cancer patients who undergo chemotherapy: Some issues

Journal of viral hepatitis, 2020-12, Vol.27 (12), p.1508-1508

2020

Volltextzugriff (PDF)

Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials

Hepatology research, 2020-10, Vol.50 (10), p.1109-1117

2020

Volltextzugriff (PDF)

The efficacy of multi‐disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patients

The Kaohsiung journal of medical sciences, 2024-06, Vol.40 (6), p.575-582

2024

Volltextzugriff (PDF)

Third vaccine boosters and anti‐S‐IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma

The Kaohsiung journal of medical sciences, 2024-05, Vol.40 (5), p.477-488

2024

Volltextzugriff (PDF)

Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals

Journal of gastroenterology and hepatology, 2017-10, Vol.32 (10), p.1754-1762

2017

Volltextzugriff (PDF)

Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease

The American journal of gastroenterology, 2021-09, Vol.116 (9), p.1924-1928

2021

Volltextzugriff (PDF)

Unawareness of hepatitis B infection and lack of surveillance are associated with severity of hepatocellular carcinoma

The Kaohsiung journal of medical sciences, 2023-11, Vol.39 (11), p.1145-1154

2023

Volltextzugriff (PDF)

Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines

The Kaohsiung journal of medical sciences, 2016-02, Vol.32 (2), p.68-73

2016

Volltextzugriff (PDF)

Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health‐related quality of life in East Asian patients with hepatitis C virus infection

Journal of viral hepatitis, 2018-12, Vol.25 (12), p.1429-1437

2018

Volltextzugriff (PDF)

The effect of interferon‐free regimens on health‐related quality of life in East Asian patients with chronic hepatitis C

Liver international, 2018-07, Vol.38 (7), p.1179-1187

2018

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library - AutoHoldings Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(187)

Publikationsform

Artikel
(220)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(176)
Science & Technology
(176)
Humans
(155)
Male
(119)
Female
(113)
Gastroenterology & Hepatology
(104)
Middle Aged
(97)
Adult
(83)
Aged
(61)
Medicine, Research & Experimental
(61)
Research & Experimental Medicine
(61)
Hepatitis C
(58)
Hepatitis C Virus
(50)
Hepatitis C, Chronic - Drug Therapy
(42)
Hepatocellular Carcinoma
(38)
Biological And Medical Sciences
(36)
Medical Sciences
(36)
Antiviral Agents - Therapeutic Use
(35)
Internal Medicine
(35)
Liver Cirrhosis
(33)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Wiley Online Library
(222)
Journals@OVID
(219)
MEDLINE
(156)
EZB Electronic Journals Library
(125)
Ingenta
(121)
Wiley Online Library
(114)
IngentaConnect Journals
(93)
Elsevier ScienceDirect Journals Complete
(74)
Publisher or Other Site
(23)
Nature International Weekly Journal of Science
(14)
HEAL-Link subscriptions: Springer Book Series
(3)
Oxford Journals
(1)

7 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Modelling NAFLD disease burden in four Asian regions—2019‐2030

Treatment of chronic hepatitis C in Asia: When East meets West

Editorial: PNPLA3 genotype and liver diseases—more than non‐alcoholic fatty liver disease

Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta‐analysis of a complex issue

Path from the discovery to the elimination of hepatitis C virus: Honoring the winners of the Nobel Prize in Physiology or Medicine 2020

Letter to the Editor: Regional Epidemics of Nonalcoholic Fatty Liver Disease: Timing of Westernization and Ethnicity Matter

Impact of interleukin‐1β single nucleotide polymorphisms and depressive symptoms in individuals with chronic viral hepatitis

Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response

Role of interleukin‐28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

Long-term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety

The interplay of metabolic dysfunction‐associated fatty liver disease and viral hepatitis on liver disease severity: A large community‐based study in a viral endemic area

Exosome‐derived differentiation antagonizing non‐protein coding RNA with risk of hepatitis C virus‐related hepatocellular carcinoma recurrence

More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma

The identification and phylogenetic analysis of SARS‐CoV‐2 delta variants in Taiwan

Prevalence, proportions of elevated liver enzyme levels, and long-term cardiometabolic mortality of patients with metabolic dysfunction-associated steatotic liver disease

Severe acute exacerbation of HCV infection in cancer patients who undergo chemotherapy: Some issues

Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials

The efficacy of multi‐disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patients

Third vaccine boosters and anti‐S‐IgG levels: A comparison of homologous and heterologous responses and poor immunogenicity in hepatocellular carcinoma

Reactivation of hepatitis B in patients of chronic hepatitis C with hepatitis B virus infection treated with direct acting antivirals

Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease

Unawareness of hepatitis B infection and lack of surveillance are associated with severity of hepatocellular carcinoma

Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines

Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health‐related quality of life in East Asian patients with hepatitis C virus infection

The effect of interferon‐free regimens on health‐related quality of life in East Asian patients with chronic hepatitis C

Aktive Filter

Suchergebnisse filtern